Symbol
ALLO on Nasdaq
Investment type
Equity - Shares of Stock
Class
COMMON STOCK
Latest Disclosed Ownership
10.9M shares
Security Ownership
5.1%

David D. Chang, M.D., Ph.D. ownership in Allogene Therapeutics, Inc. COMMON STOCK (ALLO)

2025-02-13 - David D. Chang, M.D., Ph.D. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 10.9M shares of Allogene Therapeutics, Inc. COMMON STOCK (ALLO). This represents 5.1% percent ownership of the company.